Skip to content
zarza zarza
Advertisement

Olaratumab, Goodbye?

24/01/2019 18 min
Olaratumab, Goodbye?

Listen "Olaratumab, Goodbye?"

Episode Synopsis

Olaratumab received accelerated approval in 2016 under the condition a phase III study would confirm its benefit. It didn't. We explore some possible explanations why a seemingly promising drug for a tough disease hasn't panned out...

ZARZA Studio — Your station on air today: library, music clock, schedule, studio and reports, from the browser.

Meet ZARZA Studio
on air now stations in the catalogue 1,829,025 podcasts countries